These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23085051)

  • 1. Re: comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis: s. P. Kim, R. H. Thompson, s. A. Boorjian, C. J. Weight, L. C. Han, m. H. Murad, N. D. Shippee, p. J. Erwin, B. A. Costello, g. K. Chow and B. C. Leibovich j urol 2012; 188: 51-57.
    MacLennan S; Lam T; Imamura M; Dahm P; Canfield S; Ljungberg B; N'Dow J
    J Urol; 2013 Mar; 189(3):1166-7. PubMed ID: 23085051
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy R. H. Thompson, S. A. Boorjian, C. M. Lohse, B. C. Leibovich, E. D. Kwon, J. C. Cheville and M. L. Blute J Urol 2008; 179: 468-473.
    Bhandari M; Siva S
    J Urol; 2008 Oct; 180(4):1568-9; author reply 1569. PubMed ID: 18718608
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis.
    Kim SP; Thompson RH; Boorjian SA; Weight CJ; Han LC; Murad MH; Shippee ND; Erwin PJ; Costello BA; Chow GK; Leibovich BC
    J Urol; 2012 Jul; 188(1):51-7. PubMed ID: 22591957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Severity of Preoperative Proteinuria is a Risk Factor for Overall Mortality in Patients Undergoing Nephrectomy: D. Y. Yang, R. H. Thompson, H. B. Zaid, C. M. Lohse, A. D. Rule, S. A. Boorjian, B. C. Leibovich, J. C. Cheville and M. K. Tollefson J Urol 2017;198:795-802.
    Gul D; Cimen HI; Gokce A
    J Urol; 2018 Jun; 199(6):1631. PubMed ID: 29555545
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Outcomes following partial nephrectomy by tumor size P. L. Crispen, S. A. Boorjian, C. M. Lohse, T. S. Sebo, J. C. Cheville, M. L. Blute and B. C. Leibovich J Urol 2008; 180: 1912-1917.
    Cimen HI; Serefoglu EC; Balbay MD
    J Urol; 2009 Sep; 182(3):1232; author reply 1232. PubMed ID: 19625039
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: histological subtype is an independent predictor of outcome for patients with renal cell carcinoma: B. C. Leibovich, C. M. Lohse, P. L. Crispen, S. A. Boorjian, R. H. Thompson, M. L. Blute and J. C. Cheville J Urol 2010; 183: 1309–1316.
    Dogan B; Canda AE; Akbulut Z; Balbay MD
    J Urol; 2010 Nov; 184(5):2211; author reply 2211-2. PubMed ID: 20884030
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Variation in Surgical Margin Status by Surgical Approach among Patients Undergoing Partial Nephrectomy for Small Renal Masses: W. Tabayoyong, R. Abouassaly, J. E. Kiechle, E. E. Cherullo, N. J. Meropol, N. D. Shah, S. Dong, R. H. Thompson, M. C. Smaldone, H. Zhu, S. Ialacci and S. P. Kim J Urol 2015;194:1548-1553.
    Bhattar R; Yadav SS; Priyadarshi S; Tomar V
    J Urol; 2016 Sep; 196(3):960. PubMed ID: 27311408
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional study: R. H. Thompson, I. Frank, C. M. Lohse, I. R. Saad, A. Fergany, H. Zincke, B. C. Leibovich, M. L. Blute and A. C. Novick. J Urol 2007; 177: 471-476.
    Richstone L; Kavoussi LR
    J Urol; 2007 Sep; 178(3 Pt 1):1119; author reply 1119-20. PubMed ID: 17640684
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy: R. H. Breau, P. L. Crispen, R. E. Jimenez, C. M. Lohse, M. L. Blute and B. C. Leibovich J Urol 2010; 183: 903-908.
    Cimen HI; Canda AE; Balbay MD
    J Urol; 2010 Nov; 184(5):2212; author reply 2212-3. PubMed ID: 20864129
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply by authors.
    J Urol; 2013 Mar; 189(3):1167-8. PubMed ID: 23520639
    [No Abstract]   [Full Text] [Related]  

  • 11. A Phase II Study of Pazopanib in Patients with Localized Renal Cell Carcinoma to Optimize Preservation of Renal Parenchyma.
    Rini BI; Plimack ER; Takagi T; Elson P; Wood LS; Dreicer R; Gilligan T; Garcia J; Zhang Z; Kaouk J; Krishnamurthi V; Stephenson AJ; Fergany A; Klein EA; Uzzo RG; Chen DY; Campbell SC
    J Urol; 2015 Aug; 194(2):297-303. PubMed ID: 25813447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Factors influencing renal function reduction after partial nephrectomy. C. Song, J. K. Bang, H. K. Park and H. Ahn. J Urol 2009; 181: 48-54.
    Park BK
    J Urol; 2009 Jul; 182(1):395; author reply 395-6. PubMed ID: 19450835
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass: P. H. Shah, M. A. Alom, B. C. Leibovich, R. H. Thompson, R. G. Uzzo, L. R. Kavoussi, L. Richstone, B. Bhindi, E. B. Habermann, V. Joshi and S. A. BoorjianJ Urol 2018; 200: 981-988.
    Neves JB; Tran MGB
    J Urol; 2019 Mar; 201(3):626-627. PubMed ID: 30759713
    [No Abstract]   [Full Text] [Related]  

  • 14. Value of Nephrometry Score Constituents on Perioperative Outcomes and Split Renal Function in Patients Undergoing Minimally Invasive Partial Nephrectomy.
    Watts KL; Ghosh P; Stein S; Ghavamian R
    Urology; 2017 Jan; 99():112-117. PubMed ID: 27038982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Partial nephrectomy in the setting of metastatic renal cell carcinoma: K. N. Babaian, M. M. Merrill, S. Matin, P. Tamboli, N. M. Tannir, E. Jonasch, C. G. Wood and J. A. Karam J Urol 2014; 192: 36-42.
    Giri V; Jha AK; Yadav SS
    J Urol; 2015 Feb; 193(2):733; discussion 733-4. PubMed ID: 25445577
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Functional recovery after partial nephrectomy: effects of volume loss and ischemic injury: M. N. Simmons, S. P. Hillyer, B. H. Lee, A. F. Fergany, J. Kaouk and S. C. Campbell. J Urol 2012; 187: 1667-1673.
    Matin SF
    J Urol; 2012 Sep; 188(3):1048-9. PubMed ID: 22819102
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-neoplastic parenchymal changes in kidney cancer and post-partial nephrectomy recovery of renal function.
    Bazzi WM; Chen LY; Cordon BH; Mashni J; Sjoberg DD; Bernstein M; Russo P
    Int Urol Nephrol; 2015 Sep; 47(9):1499-502. PubMed ID: 26265107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Systematic review and meta-analysis of perioperative and oncologic outcomes of laparoscopic cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal tumors: T. Klatte, S. F. Shariat and M. Remzi. J Urol 2014; 191: 1209-1217.
    Larcher A; Fossati N; Lazzeri M; Buffi N; Guazzoni G
    J Urol; 2014 Dec; 192(6):1887-8. PubMed ID: 25192802
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Percutaneous renal cryoablation: local control at mean 26 months of followup. T. D. Atwell, M. R. Callstrom, M. A. Farrell, G. D. Schmit, D. A. Woodrum, B. C. Leibovich, G. K. Chow, D. E. Patterson, M. L. Blute and J. W. Charboneau. J Urol 2010;184: 1291-1295.
    Ivanowicz AN; Wakeman CM; Gaston KE; Teigland CM
    J Urol; 2011 Sep; 186(3):1157. PubMed ID: 21784479
    [No Abstract]   [Full Text] [Related]  

  • 20. [Functional results of partial nephrectomy for kidney tumors].
    Petrov SB; Shpilenia ES; Shkarupa DD
    Vestn Khir Im I I Grek; 2009; 168(4):85-7. PubMed ID: 19947426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.